Frontlight ResearchEarly access
Liver and biliary tract cancer trials in United States
302 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleAnti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 72
- Run by
- Dan Zandberg
See details and how to joinNCT04114136 - No phaseTaking peoplePreventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Where
- Ann Arbor, Aurora, Baltimore, Birmingham, Boston, Charleston, Cleveland, Columbia, Dallas, Decatur, Durham, Houston, Little Rock, Long Beach, Louisville, Madison, Miami, New York, Omaha, Palo Alto, Philadelphia, Portland, Sacramento, Salisbury, Salt Lake City, San Diego, Seattle, St Louis, Tampa, The Bronx, Tucson, Washington D.C., West Haven, West Los Angeles
- Age
- 18 years to 75 years
- People
- 4,700
- Run by
- VA Office of Research and Development
See details and how to joinNCT05486572 - Phase 1Taking peopleA Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
- Where
- Houston
- Age
- 18 years and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07116486 - Phase 2Taking peopleY-90 Treatment Response Using Transarterial Radioembolization
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- Thomas Jefferson University
See details and how to joinNCT07145801 - Phase 1Taking peopleDose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- Where
- Fort Worth, Los Angeles, West Valley City
- Age
- 18 years and over
- People
- 40
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT07517198 - Phase 2Not yet taking people in United StatesPreoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial
- Where
- Chicago
- Age
- 18 years and over
- People
- 44
- Run by
- Northwestern University
See details and how to joinNCT07639528 - Phase 2Taking peopleTranslation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 40
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07225114 - No phaseTaking peopleIntravital Microscopy in Human Solid Tumors
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 85
- Run by
- Mayo Clinic
See details and how to joinNCT03823144 - No phaseTaking peopleTCF-001 TRACK (Target Rare Cancer Knowledge) Study
- Where
- Cambridge
- Age
- 18 years and over
- People
- 400
- Run by
- TargetCancer Foundation
See details and how to joinNCT04504604 - Phase 2Taking peopleTherasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
- Where
- Chicago, DeKalb, Geneva, Grayslake, Lake Forest, Orland Park, Warrenville
- Age
- 18 years and over
- People
- 200
- Run by
- Northwestern University
See details and how to joinNCT05620771 - Phase 1/2Taking peopleSafety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
- Where
- Germantown, Memphis
- Age
- Up to 30 years
- People
- 64
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT05468359 - No phaseTaking peopleThe Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
- Where
- Rochester
- Age
- 18 years and over
- People
- 12
- Run by
- New Phase Ltd.
See details and how to joinNCT07224464 - Phase 1Taking peopleRadioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 16
- Run by
- Mayo Clinic
See details and how to joinNCT06058663 - Phase 1Taking peopleBrodalumab in the Treatment of Immune-Related Adverse Events
- Where
- New York
- Age
- 18 years and over
- People
- 11
- Run by
- Brian Henick, MD
See details and how to joinNCT06673329 - No phaseTaking peopleComputer Guided Microwave Liver Ablation
- Where
- Boston, Lebanon
- Age
- 18 years to 90 years
- People
- 84
- Run by
- NE Scientific INC
See details and how to joinNCT07226869 - Phase 1Taking peopleTargeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
- Where
- Baltimore
- Age
- 18 years and over
- People
- 25
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06564623 - Phase 2Taking people68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
- Where
- Cleveland
- Age
- 18 years and over
- People
- 10
- Run by
- Melissa Lumish
See details and how to joinNCT06852820 - No phaseTaking people4D-MRI for Precision Medicine
- Where
- Charlottesville
- Age
- 18 years to 82 years
- People
- 100
- Run by
- University of Virginia
See details and how to joinNCT04657042 - Phase 2Not yet taking people in United StatesMaintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer
- Where
- Cleveland
- Age
- 19 years and over
- People
- 16
- Run by
- Amit Mahipal
See details and how to joinNCT07226063 - No phaseNot yet taking people in United StatesSocial Determinants of Health HCC Trial
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 75
- Run by
- University of Southern California
See details and how to joinNCT07568457 - No phaseTaking peopleTumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- Where
- Columbia
- Age
- 18 years and over
- People
- 620
- Run by
- University of Missouri-Columbia
See details and how to joinNCT02838836 - Phase 1Taking peopleIpilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
- Where
- Honolulu
- Age
- 18 years and over
- People
- 15
- Run by
- University of Hawaii
See details and how to joinNCT07075120 - Phase 1Taking peopleA Study of MGC028 in Participants With Advanced Solid Tumors
- Where
- Boston, Grand Rapids, New York, San Antonio, San Francisco, West Valley City
- Age
- 18 years and over
- People
- 124
- Run by
- MacroGenics
See details and how to joinNCT06723236 - Phase 2Taking peopleEvaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
- Where
- Baltimore, Dallas, Fort Worth, Nashville
- Age
- 18 years and over
- People
- 220
- Run by
- Riboscience, LLC.
See details and how to joinNCT07175441 - Phase 2Taking peopleY-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Beth Israel Deaconess Medical Center
See details and how to joinNCT05655949